Please login to the form below

Not currently logged in
Email:
Password:

Spiolto Respimat

This page shows the latest Spiolto Respimat news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim returns to growth after US turnaround

Boehringer Ingelheim returns to growth after US turnaround

fibrosis treatmentRespimat in COPD and Spiriva Respimat for asthma.

Latest news

  • Boehringer hails its 'landmark year' in respiratory Boehringer hails its 'landmark year' in respiratory

    We are also looking at Spiriva Respimat in paediatric asthma patients because there is an unmet medical need there.”. ... Spiolto is positioned as offering greater benefits for patients and physicians than Spiriva and was approved in its first European

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics